S&P 500

DXCM

DexCom

latest move

-6.39%

2026-10-21

4 sessions · 2026-07-16 → 2026-10-21 · avg 11.14% · largest 19.00%

DexCom designs and sells continuous glucose monitoring (CGM) systems for diabetes and metabolic health, including the G7, G6, Dexcom ONE+ and Stelo products. It operates in healthcare equipment.

Price history

stitched from the price window carried by each report

Every session it moved

newest first

2026-10-21Bullish

-6.39%24 hours change

No confirmed catalyst; Quiver attributes the 6.39% drop on 2.05x volume to pre-earnings positioning, unconfirmed.

read the report →

2026-08-03Bullish

+19.00%weekly change

DexCom stock surged after reporting strong Q2 2026 earnings beats, raising full-year guidance, and showing margin expansion.

read the report →

2026-07-31Bullish

+11.95%24 hours change

DexCom stock surged after beating Q2 2026 revenue and EPS estimates and raising its full-year guidance.

read the report →

2026-07-16Bullish

+7.22%24 hours change

The stock rose on analyst price target upgrades, strong peer earnings from Abbott, and Canadian authorization for the Dexcom G7.

read the report →